BAY 59-7939 (rivaroxaban)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 59-7939 (rivaroxaban), covering 2009-05-08 to 2009-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Phase 2]